Breaking News Instant updates and real-time market news.

BGNE

BeiGene

$163.02

-4.42 (-2.64%)

07:43
01/13/20
01/13
07:43
01/13/20
07:43

BeiGene, EUSA Pharma announce development deal for SYLVANT, QARZIBA

EUSA Pharma and BeiGene announced that they have entered into an exclusive development and commercialization agreement for the orphan biologic products SYLVANT and QARZIBA in Greater China. Under the terms of the agreement, EUSA has granted BeiGene exclusive rights to SYLVANT in Greater China and to QARZIBA in mainland China. Under the agreement, BeiGene will fund and undertake all clinical development and regulatory submissions in the territories, and will launch and commercialize both products once approved. EUSA will receive an upfront payment and be eligible to receive payments upon the achievement of regulatory and commercial milestones up to a total of $160 million. EUSA will also be eligible to receive tiered royalties on future product sales.

  • 13

    Jan

  • 27

    Feb

BGNE BeiGene
$163.02

-4.42 (-2.64%)

12/29/19
PIPR
12/29/19
NO CHANGE
Target $165
PIPR
Neutral
Piper Jaffray encouraged by BeiGene's tislelizumab approval
Piper Jaffray analyst Tyler Van Buren notes BeiGene has announced that tislelizumab was approved in China for relapsed/refractory classical Hodgkin's lymphoma, which comes just before year-end and will allow BeiGene to submit for NRDL reimbursement inclusion by the end of 2020. The analyst models cHL sales for tislelizumab in China surpassing $100M by the late 2020s, but believes that the bladder cancer indication could be several-fold larger. Van Buren is encouraged by the approval as some had thought that it was taking too long, but keeps a Neutral rating and a $165 price target on the shares given the recent ASPEN trial miss.
12/30/19
GUGG
12/30/19
NO CHANGE
GUGG
Neutral
BeiGene approval for tislelizumab may remove 'small overhang,' says Guggenheim
Guggenheim analyst Michael Schmidt said Chinese regulatory approval of tislelizumab for the treatment of patients with Hodgkin's lymphoma is in line with his expectation and may remove a "small overhang" on BeiGene shares. It is also important that approval came before the end of 2019, which qualifies tislelizumab for price negotiation and possible inclusion in the National Reimbursement Drug List in late 2020, Schmidt said. He keeps a Neutral rating on BeiGene shares.
01/03/20
HCWC
01/03/20
NO CHANGE
HCWC
Buy
Ligand royalties from Amgen may rise, but Novan hits bump, says H.C Wainwright
H.C. Wainwright analyst Joseph Pantginis noted that Ligand (LGND) partner Amgen (AMGN) announced the closing of its new 20.5% stake in BeiGene (BGNE) yesterday after the close, explaining that this could result in a likely bump up in Kyprolis royalty revenue as BeiGene is expected to commercialize Kyprolis in China over the next five to seven years. However, also after the close yesterday, another Ligand partner, Novan (NOVN), reported that the primary endpoint was missed in both studies testing SB206 in molloscum contagiosum patients. Until Novan gets FDA feedback about a potential path forward for SB206, he thinks investors will keep the program out of their estimates for Ligand's future revenue, said Pantginis. He maintains a Buy rating and $214 price target on Ligand shares.
01/08/20
RAJA
01/08/20
UPGRADE
Target $2.5
RAJA
Outperform
Raymond James upgrades Leap Therapeutics to Outperform on BeiGene deal
Raymond James analyst David Novak upgraded Leap Therapeutics to Outperform from Market Perform with a $2.50 price target. With a "strong" partner in BeiGene (BGNE) and a recapitalized balance sheet removing the financial overhang, Leap is now well positioned to unlock potential value from DKN-01 throughout the next year, Novak tells investors in a research note. The analyst is impressed with the company's ability to attract a "marquee partner" in BeiGene and believes Leap is well capitalized into 2021.

TODAY'S FREE FLY STORIES

TTPH

Tetraphase

$3.84

0.97 (33.80%)

18:50
01/22/20
01/22
18:50
01/22/20
18:50
Syndicate
Tetraphase announces $17.5M of financings priced at-the-market »

Tetraphase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJM

J.M. Smucker

$107.00

-0.77 (-0.71%)

18:39
01/22/20
01/22
18:39
01/22/20
18:39
Initiation
J.M. Smucker initiated  »

J.M. Smucker initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

  • 26

    Feb

MYGN

Myriad Genetics

$28.71

0.34 (1.20%)

18:37
01/22/20
01/22
18:37
01/22/20
18:37
Hot Stocks
Myriad Genetics submits sPMA application to FDA for myChoice CDx test »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

HSY

Hershey

$152.45

-0.355 (-0.23%)

18:36
01/22/20
01/22
18:36
01/22/20
18:36
Initiation
Hershey initiated  »

Hershey initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

DCPH

Deciphera

$66.79

0.2 (0.30%)

18:32
01/22/20
01/22
18:32
01/22/20
18:32
Recommendations
Deciphera analyst commentary  »

Piper Sandler says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGS

B&G Foods

$16.25

0.195 (1.21%)

18:28
01/22/20
01/22
18:28
01/22/20
18:28
Initiation
B&G Foods initiated  »

B&G Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVGW

Calavo Growers

$80.49

0.23 (0.29%)

18:25
01/22/20
01/22
18:25
01/22/20
18:25
Initiation
Calavo Growers initiated  »

Calavo Growers initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LW

Lamb Weston

$91.19

0.01 (0.01%)

18:21
01/22/20
01/22
18:21
01/22/20
18:21
Initiation
Lamb Weston initiated  »

Lamb Weston assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

FLO

Flowers Foods

$21.75

-0.27 (-1.23%)

18:18
01/22/20
01/22
18:18
01/22/20
18:18
Initiation
Flowers Foods initiated  »

Flowers Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$70.25

-0.32 (-0.45%)

18:15
01/22/20
01/22
18:15
01/22/20
18:15
Initiation
Kellogg initiated  »

Kellogg initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 17

    Feb

GIS

General Mills

$53.97

-0.37 (-0.68%)

, WMT

Walmart

$116.10

0.53 (0.46%)

18:12
01/22/20
01/22
18:12
01/22/20
18:12
Initiation
General Mills, Walmart, Kellogg initiated  »

General Mills initiated…

GIS

General Mills

$53.97

-0.37 (-0.68%)

WMT

Walmart

$116.10

0.53 (0.46%)

K

Kellogg

$70.25

-0.32 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 17

    Feb

  • 18

    Feb

JJSF

J & J Snack Foods

$183.94

-0.28 (-0.15%)

18:07
01/22/20
01/22
18:07
01/22/20
18:07
Initiation
J & J Snack Foods initiated  »

J & J Snack Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 11

    Feb

THS

TreeHouse

$46.83

-0.085 (-0.18%)

18:04
01/22/20
01/22
18:04
01/22/20
18:04
Initiation
TreeHouse initiated  »

TreeHouse assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 17

    Feb

HBM

Hudbay Minerals

$3.41

-0.12 (-3.40%)

18:03
01/22/20
01/22
18:03
01/22/20
18:03
Upgrade
Hudbay Minerals rating change  »

Hudbay Minerals upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TRQ

Turquoise Hill

$0.68

-0.0221 (-3.15%)

18:02
01/22/20
01/22
18:02
01/22/20
18:02
Upgrade
Turquoise Hill rating change  »

Turquoise Hill upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

STLD

Steel Dynamics

$32.02

0.11 (0.34%)

18:02
01/22/20
01/22
18:02
01/22/20
18:02
Earnings
Steel Dynamics CEO says company 'constructive' regarding NA steel market »

"Based on domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

STLD

Steel Dynamics

$32.02

0.11 (0.34%)

18:01
01/22/20
01/22
18:01
01/22/20
18:01
Earnings
Steel Dynamics reports Q4 adjusted EPS 62c, consensus 55c »

Reports Q4 revenue $2.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SQ

Square

$68.74

0.42 (0.61%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

17:59
01/22/20
01/22
17:59
01/22/20
17:59
Hot Stocks
Square introduces Lightning Development Kit tools for Bitcoin wallet developers »

The Square Crypto team…

SQ

Square

$68.74

0.42 (0.61%)

BITCOIN

Bitcoin

$0.00

(0.00%)

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

NVCR

Novocure

$94.80

-0.83 (-0.87%)

17:59
01/22/20
01/22
17:59
01/22/20
17:59
Hot Stocks
NovoCure chairman sells 133,777 ordinary shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

KHC

Kraft Heinz

$30.65

-0.37 (-1.19%)

17:52
01/22/20
01/22
17:52
01/22/20
17:52
Initiation
Kraft Heinz initiated  »

Kraft Heinz initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$68.74

0.42 (0.61%)

17:50
01/22/20
01/22
17:50
01/22/20
17:50
Periodicals
Square wins U.S patent for crypto-to-fiat payments network, Coindesk says »

Paddy Baker of Coindesk,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

QCRH

QCR Holdings

$41.92

0.13 (0.31%)

17:50
01/22/20
01/22
17:50
01/22/20
17:50
Hot Stocks
Breaking Hot Stocks news story on QCR Holdings »

QCR Holdings higher by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CPB

Campbell Soup

$48.56

-0.01 (-0.02%)

17:48
01/22/20
01/22
17:48
01/22/20
17:48
Initiation
Campbell Soup initiated  »

Campbell Soup initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$32.29

-0.475 (-1.45%)

17:45
01/22/20
01/22
17:45
01/22/20
17:45
Initiation
Conagra Brands initiated  »

Conagra Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

AMZN

Amazon.com

$1,887.32

-4.96 (-0.26%)

17:43
01/22/20
01/22
17:43
01/22/20
17:43
Periodicals
U.N. experts demand investigation into alleged Bezos hack, Reuters says »

U.N. special rapporteurs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 30

    Jan

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.